Medicines Optimisation
Following a process of stakeholder engagement and due diligence to provide the necessary assurances and clinical specifications, the CCG in the North East of England commissioned a review of 6 clinical areas, incorporating a formulary review of 16 therapies within:
- Mental health
- Oral contraception
- Dermatology
- Pen needles
- Oral Nutritional supplements
- Ulcerative colitis
MMS® worked in collaboration with commissioning groups and pharma industry to support a QIPP plan and provide both significant and tangible outcomes.